FDA Drug Recalls

Recalls / Brands / Levoxyl

Levoxyl

26 FDA drug recalls involving brand “Levoxyl.

DateClassProductFirm
2025-07-29Class IILevoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., NPfizer
2021-03-15Class IILEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADE Cardinal Health Inc.
2018-12-06Class IILevoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Pfizer Inc.
2016-11-07Class IILEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and DistribuPfizer Inc.
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and bKing Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and bKing Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and bKing Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and bKing Legacy, a wholly owned subsidiary of Pfizer
2013-04-30Class IILevoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and King Legacy, a wholly owned subsidiary of Pfizer
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b)Pfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b)Pfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and bPfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b)Pfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and Pfizer Inc.
2013-03-28Class IILevoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and bPfizer Inc.